Auralis Overview

  • Founded
  • 2005
  • Status
  • Acquired/​Merged
  • Employees
  • 3
  • Latest Deal Type
  • M&A

Auralis General Information


Developer of generic drugs. The company develops generic drugs for the areas of critical care and pediatrics.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Medical Supplies
Primary Office
  • Daresbury Innovation Centre
  • Halton WA4 4FS
  • England, United Kingdom
+44 01925 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Auralis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 28-May-2010 00.00 Completed Startup
1. Early Stage VC 01-Apr-2008 00.00 00.00 Completed Startup
To view Auralis’s complete valuation and funding history, request access »

Auralis Board Members (1)

Name Representing Role Since
Helen Shaw Self Board Member 000 0000
To view Auralis’s complete board members history, request access »

Auralis Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Auralis Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aquarius Equity Partners Venture Capital Minority 000 0000 000000 0
To view Auralis’s complete investors history, request access »